As anticipated, the most significant difference was found with NPM1mut/FLT3-ITD CD34+CD38− leukemic cells (MFI p = 0.0151) (Figure 5E), further confirming very high CD123 expression in this AML subset. The gene discussed is CD38; the disease is acute myeloid leukemia.